What's a Screening?
TO FIND A SCREENING IN YOUR COMMUNITY
CALL 888-928-7475
What is a stroke, abdominal aortic aneursym (AAA) & PAD Screening?
The stroke, AAA and PAD screening is a quick and painless way to give you information about your vascular health. A physician with expertise in vascular disease will provide you and your primary care physician with the results of your screening within one week. If further follow-up is recommended, this information will be provided to both you and your primary care physician.
- Stroke remains the 3rd leading cause of death in the U.S, and 4 out of 5 people have no apparent symptoms or warning prior to a stroke. *
- Thousands die each year from rupture of an abdominal aortic aneurysm. At least 95% of these can be successfully treated if detected prior to rupture. *
- Estimates are as high as 1/3 of older Americans have some form of peripheral arterial disease (PAD). Difficulty walking and/or pain in the calf area of your legs could mean the onset of serious issues in the arteries of your legs. *
* Sources: Society for Vascular Surgery & American College of Cardiology
For additional information, please call a Vascular Screening Specialist at 888-9AT-RISK or 888-928-7475.
Why participate in a screening?
The good news is 80% of strokes can be prevented and other peripheral vascular problems can often be easily managed if diagnosed early. Early detection is the key to a course of action that could be lifesaving.
Screening Dates & Locations
Navix, a leading provider of cardiovascular services, partners with hospitals and physician practices to provide a full range of non-invasive heart and vascular diagnostic services, including vascular ultrasound, echocardiography, nuclear medicine and Holter monitoring. Navix's Physician Preceptorship for the Interpretation of Non-Invasive Vascular Ultrasound is one of the most comprehensive programs available in the United States.
Navix Corporation Headquarters, 100 Myles Standish Boulevard, Taunton, MA 02780
Navix™ is a trademark of Navix Diagnostix, Inc.